Back to search results

Comparing Aerobic Exercise to Aerobic Plus Yoga for Weight Loss

This study is looking at whether adding yoga to a weight loss program helps adults who are overweight or have obesity lose more weight. You could be eligible if you are at least 18 years old and have a body mass index (BMI) of 25.0 kg/m2 or higher. The study will compare two groups: one group will follow a reduced-calorie diet and do aerobic exercise, and the other group will follow the same diet but do both aerobic exercise and yoga. Researchers will measure your body weight at several points over 12 months to see which approach is more effective. The current status of this study is unclear, but it plans to enroll about 290 participants.

Study design
This interventional study plans to enroll 290 participants to compare two different exercise programs for weight loss.
What's involved
You would participate in weekly group behavioral sessions for the first 6 months, then twice a month for the next 6 months. You would also follow a reduced-energy diet and an exercise plan for 12 months.
Compensation
Not stated in the trial record.
Follow-up
Your body weight will be measured at 3, 6, 9, and 12 months to track your progress.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06636773

Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.

Recruiting
NAAges 18+InterventionalTreatment
University of Kansas Medical Center
~290 participants
Updated 2026-01-09 on ClinicalTrials.gov
What's tested:DietAerobic ExerciseBehavioral SessionsAerobic + Yoga Exercise

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Body Weight
Measured over 0, 3, 6, 9, 12 months

Conditions

Obesity and Overweight

Explore related trials

ObesityOverweight

Where it's being run

1 sites across 1 states
Kansas1

Study leadership

  • John M. Jakicic, PhD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center

Who to contact

John M Jakicic, PhD
[email protected]
913-588-9078
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Both males and females of all race/ethnic groups are eligible for participation in this study.
at least 18 years of age. The investigators will not limit enrollment based on an upper age provided that the participant meets the other eligibility requirements.
Body mass index (BMI) of at least 25.0 kg/m2. The investigators will not limit enrollment based on an upper BMI level provided that the participant meets the other eligibility requirements. However, maximal weight to be eligible will be 350 pounds to meet the weight requirements for the equipment that will be used in this study.
Ability to provide informed consent prior to participation in this study.
Ability to provide clearance from their primary care physician to engage in the diet and physical activity components of the weight loss intervention.

Exclusion

Report moderate-to-vigorous exercise on \>3 days/week or a total of \>60 min/week over the past 3 months.
Engaging in any style of yoga on an average of at least 1 day/week over the past 3 months.
Report weight loss of 3% or more or participating in a weight reduction diet in the past 3 months.
Currently prescribed an anti-obesity medication.
Females who are pregnant or breastfeeding or reporting a planned pregnancy during the study period.
History of bariatric surgery.
Report a current medical condition or treatment for a medical condition that could affect body weight.
Current congestive heart failure, angina, uncontrolled arrhythmia, symptoms indicative of an increased acute risk for a cardiovascular event, prior myocardial infarction, coronary artery bypass grafting or angioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrent DVT).
Resting systolic blood pressure of 160 mmHg or more or resting diastolic blood pressure of 100 mmHg or more. If medicated for blood pressure control, the medication dose needs to be stable for at least 6 months.
Eating disorders that would contraindicate weight loss or physical activity.
Alcohol or substance abuse.
Current psychological condition that is untreated, hospitalization for a psychological condition within the past 12 months, or not being on a stable dose of treatment for at least 6 months.
Report plans to relocate to a location not accessible to the study site or having employment, personal, or travel commitments that prohibit attendance at scheduled intervention sessions or assessments.

What this trial measures

  • Body Weight0, 3, 6, 9, 12 months

    Body weight will be assessed in duplicate using a calibrated digital scale to the nearest 0.1 kg.